{ }
001122334455554433221100
001122334455554433221100

ura and dexcom partner to enhance metabolic health tracking for users

Eli Lilly"s experimental cholesterol pill, muvalaplin, has shown promising results in a mid-stage trial, significantly reducing levels of lipoprotein(a), a genetic risk factor for heart disease. The highest dose decreased Lp(a) by 70% compared to placebo, with a favorable safety profile. Analysts suggest the drug could become a blockbuster if it proves effective in preventing cardiovascular events in future trials.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.